Form 4: LivaNova PLC: Chief Human Resources Officer Hebbelinck Trui Reports Stock Transactions

Sentiment:

SEC Form 4 2 April 2024 9:21 PM

Chief Human Resources Officer of LivaNova PLC, Trui Hebbelinck, reports acquisition and disposal of ordinary shares and derivative securities, including restricted stock units and performance stock units, on March 30, 2024.

Summary

On March 30, 2024, Trui Hebbelinck, Chief Human Resources Officer of LivaNova PLC, reported transactions involving the company's ordinary shares and derivative securities.
These transactions included the vesting and settlement of restricted stock units (RSUs) and performance stock units (PSUs) into ordinary shares.
Shares were also withheld to cover tax liabilities.
Hebbelinck was granted additional RSUs, PSUs, and stock appreciation rights (SARs) that vest over a four-year period.
The vesting of PSUs is contingent upon the company's performance against targets related to free cash flow (FCF), return on investment capital (ROIC), and total shareholder return (TSR).

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices and insider transactions. The sentiment is neutral to slightly positive as it indicates alignment of management interests with shareholder value through equity-based compensation.

Positives

The granting of RSUs, PSUs, and SARs aligns the executive's interests with the long-term performance of the company.
Vesting of performance stock units is tied to key financial metrics like free cash flow, return on investment capital, and total shareholder return, incentivizing value creation.

Negatives

The disposal of shares to cover tax liabilities, while standard practice, slightly reduces the officer's direct holdings.

Risks

The value of the granted RSUs, PSUs, and SARs is subject to the future performance of LivaNova PLC's stock price.
Failure to meet performance targets related to FCF, ROIC, and TSR could result in the forfeiture of PSUs.

Future Outlook

The reporting person has been granted additional RSUs, PSUs, and SARs that will vest in the future, contingent on continued service and, in the case of PSUs, the company's performance against pre-defined financial metrics.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the compensation structure and alignment of executive interests with shareholder value.

Comparison to Industry Standards

LivaNova's executive compensation practices, including the use of RSUs, PSUs, and SARs, are consistent with industry standards for publicly traded companies of similar size and complexity.
Companies like Medtronic, Boston Scientific, and Abbott also utilize similar equity-based compensation plans to incentivize their executives.
The specific performance metrics used for PSU vesting (FCF, ROIC, and TSR) are also commonly used in the medical device industry to drive financial performance and shareholder value.

Stakeholder Impact

Shareholders: The transactions provide transparency into executive compensation and alignment of interests.
Employees: The equity-based compensation structure can motivate employees by aligning their interests with the company's performance.
Executives: The RSUs, PSUs, and SARs provide a financial incentive for executives to drive long-term value creation.

Next Steps

The newly granted RSUs, PSUs, and SARs will vest over the next four years, subject to continued service and, in the case of PSUs, the company's performance against pre-defined financial metrics.
The company's performance against the FCF, ROIC, and TSR targets will determine the number of PSUs that ultimately vest.

Key Dates

Date	Description
03/30/2020	Reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting for which occurred on March 30, 2021.
03/30/2021	Reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting for which occurred on March 30, 2022.
03/30/2021	The reporting person received a grant of 1,365 PSUs. The number of PSUs that vested was the result of the Company's performance against a target related to Free Cash Flow (FCF) for fiscal years 2021 with additional two years service condition.
03/30/2021	The reporting person received a grant of 1,365 PSUs. The number of PSUs that vested was the result of the Company's Return on Investment Capital (ROIC) for fiscal year 2021 with additional two years service condition.
03/30/2021	The reporting person was granted 2,730 PSUs. The vesting of the PSUs depended on the Company's performance against a target of the total shareholder return (TSR) for fiscal years 2021, 2022, and 2023, compared to our peer companies.
03/30/2022	Reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting for which occurred on March 30, 2023.
03/30/2023	Reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2024.
01/01/2024	Start date for the three-year period used to determine the vesting of PSUs based on the Company's TSR relative to an index of companies.
03/30/2024	Date of the reported transactions, including vesting of RSUs and PSUs, tax withholding, and grant of new RSUs, PSUs, and SARs.
03/30/2024	Reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025.
03/30/2024	Reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's free cash flow (FCF) for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator.
03/30/2024	Reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's Return on Investment Capital (ROIC) calculated for the performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator.
03/30/2024	Reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's TSR for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator.
12/31/2026	End date for the three-year period used to determine the vesting of PSUs based on the Company's TSR relative to an index of companies.
03/30/2027	Date on which PSUs granted on March 30, 2024, will vest or lapse based on the Company's FCF and ROIC performance for the period 2024-2026.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.